BioTrove Files for IPO | GenomeWeb
NEW YORK (GenomeWeb News) – BioTrove has filed with the US Securities and Exchange Commission to offer an undetermined number of its shares in an initial public offering.
 
The preliminary prospectus for the IPO did not provide an estimated range for the offering price. BioTrove expects to float on the Nasdaq and trade under the symbol “BTRV.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.